Immediate Impact
1 from Science/Nature 58 standout
Citing Papers
The interaction of innate immune and adaptive immune system
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of David Bienvenue being referenced
Abstract 1786: APVO436, a bispecific anti-CD123 x anti-CD3 ADAPTIR™ molecule for redirected T-cell cytotoxicity, induces potent T-cell activation, proliferation and cytotoxicity with limited cytokine release
2018
MOR209/ES414, a Novel Bispecific Antibody Targeting PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| David Bienvenue | 267 | 230 | 50 | 92 | 23 | 401 | |
| Emmanuel Ruffet | 133 | 236 | 42 | 28 | 12 | 381 | |
| G. Valet | 107 | 221 | 21 | 35 | 19 | 397 | |
| Wenting Zhang | 69 | 143 | 45 | 38 | 21 | 419 | |
| Anat Shahar | 72 | 260 | 40 | 31 | 24 | 376 | |
| E. Lajeunesse | 70 | 272 | 66 | 45 | 19 | 445 | |
| Beáta Biri‐Kovács | 75 | 244 | 29 | 20 | 29 | 376 | |
| Raphael Trenker | 104 | 254 | 82 | 30 | 15 | 403 | |
| Rodolphe Alves de Sousa | 161 | 167 | 9 | 41 | 24 | 404 | |
| Tin Cao | 75 | 237 | 46 | 37 | 15 | 360 | |
| Mohamad Reza Ganjalikhany | 75 | 319 | 27 | 25 | 28 | 430 |
All Works
Login with ORCID to disown or claim papers
Loading papers...